**Ayman Abouzayed, Hanna Tano, Abel Nagy, Sara S. Rinne, Fadya Wadeea and Sharmishtaa ´ Kumar et al.**

Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer Reprinted from: *Pharmaceutics* **2020**, *12*, 977, doi:10.3390/pharmaceutics12100977 . . . . . . . . . **281**
